Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

CaV1.2 Citations (13)

Originally described in: Neuronal L-type calcium channels open quickly and are inhibited slowly.
Helton TD, Xu W, Lipscombe D J Neurosci. 2005 Nov 2. 25(44):10247-51.
PubMed Journal

Articles Citing CaV1.2

Articles
MKP3 eliminates depolarization-dependent neurotransmitter release through downregulation of L-type calcium channel Cav1.2 expression. Mortensen OV. Cell Calcium. 2013 Mar;53(3):224-30. doi: 10.1016/j.ceca.2012.12.004. Epub 2013 Jan 18. PubMed
Costimulation of AMPA and metabotropic glutamate receptors underlies phospholipase C activation by glutamate in hippocampus. Kim HH, Lee KH, Lee D, Han YE, Lee SH, Sohn JW, Ho WK. J Neurosci. 2015 Apr 22;35(16):6401-12. doi: 10.1523/JNEUROSCI.4208-14.2015. PubMed
Inhibition of human N- and T-type calcium channels by an ortho-phenoxyanilide derivative, MONIRO-1. McArthur JR, Motin L, Gleeson EC, Spiller S, Lewis RJ, Duggan PJ, Tuck KL, Adams DJ. Br J Pharmacol. 2017 Jun 13. doi: 10.1111/bph.13910. PubMed
Cav 1.2 regulates osteogenesis of bone marrow-derived mesenchymal stem cells via canonical Wnt pathway in age-related osteoporosis. Fei D, Zhang Y, Wu J, Zhang H, Liu A, He X, Wang J, Li B, Wang Q, Jin Y. Aging Cell. 2019 Aug;18(4):e12967. doi: 10.1111/acel.12967. Epub 2019 May 23. PubMed
TDP-43 regulates early-phase insulin secretion via CaV1.2-mediated exocytosis in islets. Araki K, Araki A, Honda D, Izumoto T, Hashizume A, Hijikata Y, Yamada S, Iguchi Y, Hara A, Ikumi K, Kawai K, Ishigaki S, Nakamichi Y, Tsunekawa S, Seino Y, Yamamoto A, Takayama Y, Hidaka S, Tominaga M, Ohara-Imaizumi M, Suzuki A, Ishiguro H, Enomoto A, Yoshida M, Arima H, Muramatsu SI, Sobue G, Katsuno M. J Clin Invest. 2019 Jul 29;129(9):3578-3593. doi: 10.1172/JCI124481. eCollection 2019 Jul 29. PubMed
L- and T-type calcium channels control aldosterone production from human adrenals. Yang T, He M, Zhang H, Barrett PQ, Hu C. J Endocrinol. 2020 Jan;244(1):237-247. doi: 10.1530/JOE-19-0259. PubMed
Kv2.1 mediates spatial and functional coupling of L-type calcium channels and ryanodine receptors in mammalian neurons. Vierra NC, Kirmiz M, van der List D, Santana LF, Trimmer JS. Elife. 2019 Oct 30;8. pii: 49953. doi: 10.7554/eLife.49953. PubMed
Ionomycin ameliorates hypophosphatasia via rescuing alkaline phosphatase deficiency-mediated L-type Ca(2+) channel internalization in mesenchymal stem cells. Li B, He X, Dong Z, Xuan K, Sun W, Gao L, Liu S, Liu W, Hu C, Zhao Y, Shi S, Jin Y. Bone Res. 2020 Apr 26;8:19. doi: 10.1038/s41413-020-0090-7. eCollection 2020. PubMed
Tetraspanin-7 regulation of L-type voltage-dependent calcium channels controls pancreatic beta-cell insulin secretion. Dickerson MT, Dadi PK, Butterworth RB, Nakhe AY, Graff SM, Zaborska KE, Schaub CM, Jacobson DA. J Physiol. 2020 Nov;598(21):4887-4905. doi: 10.1113/JP279941. Epub 2020 Sep 1. PubMed
Disruption of Cav1.2-mediated signaling is a pathway for ketamine-induced pathology. Chen H, Vandorpe DH, Xie X, Alper SL, Zeidel ML, Yu W. Nat Commun. 2020 Aug 28;11(1):4328. doi: 10.1038/s41467-020-18167-4. PubMed
A high-affinity, partial antagonist effect of 3,4-diaminopyridine mediates action potential broadening and enhancement of transmitter release at NMJs. Ojala KS, Ginebaugh SP, Wu M, Miller EW, Ortiz G, Covarrubias M, Meriney SD. J Biol Chem. 2021 Jan-Jun;296:100302. doi: 10.1016/j.jbc.2021.100302. Epub 2021 Jan 17. PubMed
Spider Venom Peptide Pn3a Inhibition of Primary Afferent High Voltage-Activated Calcium Channels. McArthur JR, Munasinghe NR, Finol-Urdaneta RK, Adams DJ, Christie MJ. Front Pharmacol. 2021 Jan 28;11:633679. doi: 10.3389/fphar.2020.633679. eCollection 2020. PubMed
Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations. Rodan LH, Spillmann RC, Kurata HT, Lamothe SM, Maghera J, Jamra RA, Alkelai A, Antonarakis SE, Atallah I, Bar-Yosef O, Bilan F, Bjorgo K, Blanc X, Van Bogaert P, Bolkier Y, Burrage LC, Christ BU, Granadillo JL, Dickson P, Donald KA, Dubourg C, Eliyahu A, Emrick L, Engleman K, Gonfiantini MV, Good JM, Kalser J, Kloeckner C, Lachmeijer G, Macchiaiolo M, Nicita F, Odent S, O'Heir E, Ortiz-Gonzalez X, Pacio-Miguez M, Palomares-Bralo M, Pena L, Platzer K, Quinodoz M, Ranza E, Rosenfeld JA, Roulet-Perez E, Santani A, Santos-Simarro F, Pode-Shakked B, Skraban C, Slaugh R, Superti-Furga A, Thiffault I, van Jaabrsveld RH, Vincent M, Wang HG, Zacher P, Rush E, Pitt GS, Au PYB, Shashi V. Genet Med. 2021 Oct;23(10):1922-1932. doi: 10.1038/s41436-021-01232-8. Epub 2021 Jun 23. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.